Gordon Mallarkey
Gordon Mallarkey publishes mostly in Pulmonary and Respiratory Medicine, Surgery and Cardiology and Cardiovascular Medicine, on topics such as Antiplatelet Therapy and Cardiovascular Diseases, Inflammatory mediators and NSAID effects and Lung Cancer Treatments and Mutations.
- World rank
- #5,533,891 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #321,428 of 367,258
- Works
- 51
- Citations
- 404
- Citations per work
- 7.9
What does Gordon Mallarkey research?
Gordon Mallarkey's work is mostly in Medicine (42%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2753.4%
- Health Sciences2142.0%
- Medicine2142.0%
- Life Sciences24.6%
- 1Pulmonary and Respiratory Medicine12% of their works
- 2Surgery8% of their works
- 3Cardiology and Cardiovascular Medicine8% of their works
- 4Pharmacology8% of their works
- 5Oncology7% of their works
- 6Molecular Biology5% of their works
Research topics
- Antiplatelet Therapy and Cardiovascular Diseases
- Inflammatory mediators and NSAID effects
- Lung Cancer Treatments and Mutations
- Helicobacter pylori-related gastroenterology studies
- Lipoproteins and Cardiovascular Health
- Eicosanoids and Hypertension Pharmacology
- Cancer Genomics and Diagnostics
- Pharmacovigilance and Adverse Drug Reactions
Which keywords describe Gordon Mallarkey's research?
The keywords of their largest research topics: Inflammation, Clinical Trials, Targeted Therapy, Aspirin, Cancer, Clopidogrel, Cyclooxygenase-2 Inhibitors and ALK Inhibitors.
- Mutational Signatures
- Cancer Genomics
- Adverse Drug Reactions
- Helicobacter pylori
- Cholesterol-lowering
- ALK Inhibitors
- Clopidogrel
- Aspirin
- Clinical Trials
- Inflammation
- Targeted Therapy
- Cancer
- Cyclooxygenase-2 Inhibitors
- EGFR Mutations
- Gastric Cancer
- Statins
- Arachidonic Acid
- Epoxyeicosatrienoic Acids
- Pharmacovigilance
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Inflammation133 topics
- Clinical Trials92 topics
- Targeted Therapy82 topics
- Aspirin61 topic
- Cancer61 topic
- Clopidogrel61 topic
- Cyclooxygenase-2 Inhibitors61 topic
- ALK Inhibitors51 topic
- EGFR Mutations51 topic
- Cholesterol-lowering41 topic
- Gastric Cancer41 topic
- Helicobacter pylori41 topic
- Statins41 topic
- Adverse Drug Reactions31 topic
- Arachidonic Acid31 topic
- Cancer Genomics31 topic
- Epoxyeicosatrienoic Acids31 topic
- Mutational Signatures31 topic
- Pharmacovigilance31 topic
Where does Gordon Mallarkey work?
Gordon Mallarkey's main affiliation in the publication record is Robert Gordon's College, United Kingdom.
How many publications and citations does Gordon Mallarkey have?
OpenAlex counts 51 works and 404 citations for Gordon Mallarkey, an h-index of 10, ranking #5,533,891 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Gordon Mallarkey. Posts are plain text and can be reported.